# FDA 483 - Hessam Aazami, M.D. - February 04, 2020

Source: https://www.globalkeysolutions.net/records/483/hessam-aazami-md/9b477493-9c6d-419e-83ca-77fffdd96bc1

> FDA 483 for Hessam Aazami, M.D. on February 04, 2020. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Hessam Aazami, M.D.
- Inspection Date: 2020-02-04
- Product Type: drugs
- Office Name: Division of Human and Animal Food Operations - West V
- Summary: An FDA inspection of Hessam Aazami, M.D. in Canoga Park, CA, revealed a significant issue with record retention. The firm failed to retain original source records for electronic diaries for a large number of enrolled subjects following the approval of a drug's marketing application. This indicates a serious lapse in maintaining investigational records.

## Related Officers

- [Kristin M. Abaonza](https://www.globalkeysolutions.net/people/kristin-m-abaonza/cf909da8-837d-4dfe-9ccc-288b24d7bba3)

Company: https://www.globalkeysolutions.net/companies/hessam-aazami-md/30af9f83-341c-4f45-a9a3-acd8429642b0

Office: https://www.globalkeysolutions.net/offices/division-of-human-and-animal-food-operations-west-v/0f4dd01e-8e8a-4336-9abe-ce8b3d309e8b